Drägerwerk confirms guidance despite Q2 margin pressure

Published 14/07/2025, 11:44
© Reuters.

Investing.com -- Drägerwerk AG & Co. KGaA reported mixed preliminary second-quarter results on Friday, showing strong order intake but weaker sales and margins.

The German medical and safety technology company saw order intake rise 10.5% to €877 million compared to the same period last year, or 14.3% when adjusted for currency effects.

This growth was primarily driven by the Medical (TASE:BLWV) Division, where orders surged 20.3% (25.5% currency-adjusted) to approximately €537 million, boosted by a significant multi-year contract from Mexico valued in the mid-double-digit million euro range.

Despite the robust order book, quarterly net sales decreased slightly by 0.6% (1.8% currency-adjusted) to €780 million.

The company’s gross margin contracted to 43.8% from 44.3% in the prior-year period, affected by lower sales volume, product mix changes, tariffs, and currency effects.

Earnings before interest and taxes (EBIT) fell to €20 million from €40.7 million in Q2 2024.

In the Medical Division, net sales increased by 2.1% (5.0% currency-adjusted) to approximately €438 million, while the Safety Division experienced a 3.9% decline (2.0% currency-adjusted) to around €342 million.

Safety Division orders also decreased by 2% to €340 million.

Despite the quarterly performance challenges, Drägerwerk maintained its full-year 2025 guidance, projecting net sales growth of 1-5% (currency-adjusted) and an EBIT margin between 3.5% and 6.5%.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.